We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

AXA Diagnostics Srl

AXA Diagnostics offers a wide range of products, systems and services for laboratory specialists to help diagnose sev... read more Featured Products: More products

Download Mobile App





AXA Diagnostics Highlights SkyLAB752 System

By LabMedica International staff writers
Posted on 05 Feb 2018
Print article
The SkyLAB752 system (Photo courtesy of AXA Diagnostics).
The SkyLAB752 system (Photo courtesy of AXA Diagnostics).
AXA Diagnostics (Milan, Italy) participated in MEDLAB Middle East, the world’s largest attended laboratory & IVD exhibition and conference, held from February 5-8, 2018 in Dubai, UAE. AXA Diagnostics shared the booth with its sister company, Sclavo Diagnostics Int., where it provided all updates and new applications of its SkyLAB752 automated ELISA/IFA processor. Sclavo is a leading manufacturer of reagents for clinical chemistry, specific/urinary proteins, coagulation, and serology.
 
AXA Diagnostics is a partner to DASIT Group, which also comprises other leading IVD organizations, such as DASIT S.p.A. and industrial and research laboratories, such as CARLO ERBA Reagents S.r.l. and FASTER S.r.l. AXA Diagnostics develops, produces and markets IVD reagents dedicated to autoimmunity disease and instruments for the automation of all ELISA and IFA testing. The company also provides OEM equipment to fulfill the needs of automating the processing of IVD reagents.
 
The SkyLAB752 automated ELISA/IFA processor from AXA Diagnostics can simultaneously process ELISA microplates and IFA slides. The system is equipped with two innovative dispensing systems able to work simultaneously and independently. This enables the instrument to pipette an entire microplate in half the time compared to other analyzers available on the market. The movement of the manifold robotic arm does not interfere with the movement of the other two robotic arms, pipettes and microplate robotic arm, making the dispensing, washing and reading steps independent of each other. This architecture allows to maintain the execution times of each processing step aligned with the directions provided on the kit's IFU, leading to elimination of any drift effect.
 
Its innovative design allows constant access to the microplates by the washer and pipettes, even during incubation, so that the whole procedure applied to each strip can be closely followed and monitored. The SkyLAB 752 uses a LED microplate reading system that allows precision, reduced maintenance and a 3.3 OD photometric range. A state of the art LED light-source provides high performance and minimum maintenance, large measurement range and excellent reproducibility.
 
The system accommodates five positions on the working area equipped with incubators. Under the working area, two additional positions are available, one of them equipped with a shaker incubator. Each of the seven positions can contain both microplates and IFA slides. As an optional under the working area, SkyLAB 752 can accommodate from one to four positions equipped with incubators and shakers that can contain both microplates and IFA slides.
 
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory QC Panel
Assayed Respiratory Control Panel
New
cTnI/CK-MB/Myo Test
Finecare cTnI/CK-MB/Myo Rapid Quantitative Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.